Skip to main navigation Skip to search Skip to main content

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12

  • F Heitz*
  • , P Harter
  • , E Åvall-Lundqvist
  • , A Reuss
  • , P Pautier
  • , G Cormio
  • , N Colombo
  • , A Reinthaller
  • , I Vergote
  • , A Poveda
  • , P B Ottevanger
  • , L C Hanker
  • , A Leminen
  • , J Alexandre
  • , U Canzler
  • , J Sehouli
  • , J Herrstedt
  • , B Fiane
  • , M Merger
  • , A du Bois
    • *Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

Fingerprint

Explore the research areas of 'Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12'.
Sort by

Keyphrases

Medicine and Dentistry